Respiratory Distress and Elective Cesarean Section at Term
Launched by ASSIUT UNIVERSITY · Mar 8, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how to better understand and reduce the risk of a serious condition called neonatal respiratory distress syndrome in babies born by elective cesarean section. This condition can make it hard for newborns to breathe and is a leading cause of health problems and even death in infants. The researchers want to focus on pregnant women who are planning to have a cesarean section after 37 weeks of pregnancy and who have received treatment to help their baby's lungs develop. By studying these women and their babies, the goal is to identify factors that could increase the risk of respiratory issues in newborns and find ways to improve outcomes.
To be eligible for the study, women must be between 20 and 39 years old and have a single baby due to be born at or after 37 weeks. However, women with certain health issues or complications in their pregnancy will not be included. Participants can expect to undergo some simple tests to help assess their baby’s lung health and monitor any potential risks. The findings from this trial could help doctors provide better care for mothers and their babies in the future.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • 1. Maternal age of 20-39 years.
- • 2. Women with singleton pregnancy ≥ 37 weeks
- • 3. Pregnant women who received corticosteroid to enhance lung maturity and will be subjected to elective cesarian section (before onset of labour) within 1 week after administration of corticosteroid
- Exclusion Criteria:
- • 1. Women with oligohydramnios or polyhydramnios.
- • 2. Women with underlying disease requiring corticosteroids.
- • 3. Pregnant women with any medical disorders such as hypertension, diabetes, renal diseases, antiphospholipid syndrome, intrauterine growth restriction, preterm premature rupture of membrane, placenta previa, antepartum haemorrhage, on anticoagulant thereby.
- • 4. Women with confirmed fetal malformation.
- • 5. Women who will refuse to participate.
About Assiut University
Assiut University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that enhance healthcare outcomes. With a strong emphasis on innovation and collaboration, the university engages in a wide array of clinical studies across various disciplines, aiming to contribute valuable insights into disease prevention, diagnosis, and treatment. Assiut University's commitment to ethical research practices and rigorous scientific methodology ensures the integrity and reliability of its clinical trials, ultimately benefiting both the local community and the global medical landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Assiut, , Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported